BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2878694)

  • 1. A role for guanine ribonucleotides in the regulation of myeloid cell maturation.
    Wright DG
    Blood; 1987 Jan; 69(1):334-7. PubMed ID: 2878694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inosine monophosphate dehydrogenase and myeloid cell maturation.
    Knight RD; Mangum J; Lucas DL; Cooney DA; Khan EC; Wright DG
    Blood; 1987 Feb; 69(2):634-9. PubMed ID: 2879579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-phosphate dehydrogenase.
    Sokoloski JA; Blair OC; Sartorelli AC
    Cancer Res; 1986 May; 46(5):2314-9. PubMed ID: 2870796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tiazofurin on guanine nucleotide binding regulatory proteins in HL-60 cells.
    Kharbanda SM; Sherman ML; Kufe DW
    Blood; 1990 Feb; 75(3):583-8. PubMed ID: 1967538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purine metabolism in myeloid precursor cells during maturation. Studies with the HL-60 cell line.
    Lucas DL; Webster HK; Wright DG
    J Clin Invest; 1983 Dec; 72(6):1889-900. PubMed ID: 6139386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
    Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
    Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tiazofurin on protooncogene expression during HL-60 cell differentiation.
    Kharbanda SM; Sherman ML; Spriggs DR; Kufe DW
    Cancer Res; 1988 Nov; 48(21):5965-8. PubMed ID: 2901907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide).
    Lui MS; Faderan MA; Liepnieks JJ; Natsumeda Y; Olah E; Jayaram HN; Weber G
    J Biol Chem; 1984 Apr; 259(8):5078-82. PubMed ID: 6143752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective guanosine phosphate deficiency in hepatoma cells induced by inhibitors of IMP dehydrogenase.
    Kaiser WA; Herrmann B; Keppler DO
    Hoppe Seylers Z Physiol Chem; 1980 Oct; 361(10):1503-10. PubMed ID: 6108911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis.
    Jayaram HN; Cooney DA; Grusch M; Krupitza G
    Curr Med Chem; 1999 Jul; 6(7):561-74. PubMed ID: 10390601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
    Tricot GJ; Jayaram HN; Lapis E; Natsumeda Y; Nichols CR; Kneebone P; Heerema N; Weber G; Hoffman R
    Cancer Res; 1989 Jul; 49(13):3696-701. PubMed ID: 2567208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of guanine nucleotides in superoxide release by fluoride-treated neutrophils. Implications for a role of a guanine nucleotide regulatory protein.
    English D; Rizzo MT; Tricot G; Hoffman R
    J Immunol; 1989 Sep; 143(5):1685-91. PubMed ID: 2547872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targets and markers of selective action of tiazofurin.
    Weber G; Natsumeda Y; Pillwein K
    Adv Enzyme Regul; 1985; 24():45-65. PubMed ID: 2424286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular impact of inhibition of IMP dehydrogenase activity by tiazofurin.
    Weber G; Yamaji Y; Olah E; Natsumeda Y; Jayaram HN; Lapis E; Zhen WN; Prajda N; Hoffman R; Tricot GJ
    Adv Enzyme Regul; 1989; 28():335-56. PubMed ID: 2576178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of memory to the terminal differentiation inducing activity of tiazofurin in HL-60 leukemia cells.
    Sokoloski JA; Sartorelli AC
    Leuk Res; 1991; 15(5):395-402. PubMed ID: 2046392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle dependent regulation of IMP dehydrogenase activity and effect of tiazofurin.
    Szekeres T; Fritzer M; Pillwein K; Felzmann T; Chiba P
    Life Sci; 1992; 51(16):1309-15. PubMed ID: 1357518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A decrease in the intracellular guanosine 5'-triphosphate concentration is necessary for granulocytic differentiation of HL-60 cells, but growth cessation and differentiation are not associated with a change in the activation state of Ras, the transforming principle of HL-60 cells.
    Pilz RB; Huvar I; Scheele JS; Van den Berghe G; Boss GR
    Cell Growth Differ; 1997 Jan; 8(1):53-9. PubMed ID: 8993834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 2-amino-1,3,4-thiadiazole on ribonucleotide pools of leukemia L1210 cells.
    Nelson JA; Rose LM; Bennett LL
    Cancer Res; 1976 Apr; 36(4):1375-8. PubMed ID: 130972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis in IL-3-dependent hematopoietic cell lines by guanine nucleotide depletion.
    Gu JJ; Gathy K; Santiago L; Chen E; Huang M; Graves LM; Mitchell BS
    Blood; 2003 Jun; 101(12):4958-65. PubMed ID: 12609835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K-562 leukemia cells.
    Olah E; Natsumeda Y; Ikegami T; Kote Z; Horanyi M; Szelenyi J; Paulik E; Kremmer T; Hollan SR; Sugar J
    Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6533-7. PubMed ID: 2901100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.